Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Comment by hopefullon Mar 11, 2020 10:00am
97 Views
Post# 30792712

RE:RE:RE:Answering the questions again and again

RE:RE:RE:Answering the questions again and again
The company has a responsibility to shareholders not only to provide value ,which is what they have slowly been doing and where we are right now. They also have responsibility to increase shareholders investment which I'm hoping will be by the end of next year, because of its increasingly difficulties in launch the product, I believe we will see results by the end of Q4. But would finally like to see Management seriously address investors with transparency with regard to direction and goal setting and execution. This has been my biggest beef where I believe that management has not been open to their investors. But at the end of all this we hopefully can turn around in 2022 and say it was worth it when at that time might hit $1.00. Slow and steady wins the race. But please not any slower that what we have experienced thus far.
Bullboard Posts